Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Minority Interest (2019 - 2024)

Arcadia Biosciences' Minority Interest history spans 6 years, with the latest figure at -$138000.0 for Q3 2024.

  • For Q3 2024, Minority Interest changed 0.0% year-over-year to -$138000.0; the TTM value through Sep 2024 reached -$138000.0, changed 0.0%, while the annual FY2023 figure was -$138000.0, 3.76% down from the prior year.
  • Minority Interest reached -$138000.0 in Q3 2024 per RKDA's latest filing, roughly flat from -$138000.0 in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $1.5 million in Q2 2020 to a low of -$138000.0 in Q2 2023.
  • Average Minority Interest over 5 years is $303789.5, with a median of -$39000.0 recorded in 2022.
  • Peak YoY movement for Minority Interest: skyrocketed 33.17% in 2020, then crashed 600.0% in 2023.
  • A 5-year view of Minority Interest shows it stood at $827000.0 in 2020, then tumbled by 87.55% to $103000.0 in 2021, then plummeted by 229.13% to -$133000.0 in 2022, then fell by 3.76% to -$138000.0 in 2023, then changed by 0.0% to -$138000.0 in 2024.
  • Per Business Quant, the three most recent readings for RKDA's Minority Interest are -$138000.0 (Q3 2024), -$138000.0 (Q2 2024), and -$138000.0 (Q1 2024).